CD27+ IFNγ-producing γδ T cells utilize glycolytic metabolism for energy, and glucose enhances their anti-tumor activity via mTOR regulation of T-bet, EOMES, and NKG2D expression (Lopes et al, 2021; Yang et al, 2020). This evidence concerns the gene CD27 and neoplasm.